Improving the Oral Bioavailability and in vivo efficacy of the TAK 1 inhibitor, Takinib.
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
North Carolina Biotechnology Center
Start Date
February 1, 2019
End Date
January 31, 2021
Administered By
Pharmacology & Cancer Biology
Awarded By
North Carolina Biotechnology Center
Start Date
February 1, 2019
End Date
January 31, 2021